Compounds > argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-
Page last updated: 2024-09-05

argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- and erlotinib hydrochloride

argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- has been researched along with erlotinib hydrochloride in 1 studies

Compound Research Comparison

Studies
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Trials
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Recent Studies (post-2010)
(argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)-)		Studies
(erlotinib hydrochloride)		Trials
(erlotinib hydrochloride)		Recent Studies (post-2010) (erlotinib hydrochloride)
14024,3537863,033

Protein Interaction Comparison

ProteinTaxonomyargipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- (IC50)erlotinib hydrochloride (IC50)
Epidermal growth factor receptorHomo sapiens (human)0.1683
Receptor tyrosine-protein kinase erbB-2Homo sapiens (human)1.705
Serine/threonine-protein kinase B-raf Mus musculus (house mouse)0.04

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benveniste, MF; Carter, BW; de Groot, PM; Shroff, GS; Truong, MT; Viswanathan, C; Wu, CC1

Reviews

1 review(s) available for argipressin,(1-mercaptocyclohexaneacetic acid)(1)-o-ethyl-tyr(2)- and erlotinib hydrochloride

ArticleYear
Imaging on Lung Cancer and Treatment with Targeted Therapy.
    Seminars in ultrasound, CT, and MR, 2018, Volume: 39, Issue:3

    Topics: Anaplastic Lymphoma Kinase; Antineoplastic Agents; Antineoplastic Agents, Immunological; Arginine Vasopressin; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Crizotinib; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung; Lung Neoplasms; Mutation; Tomography, X-Ray Computed

2018